Home EXECUTIVES

Yehiel Tal, Chief Executive Officer of CollPlant Is Elected to the BOD of ISBF

ehiel-Tal CollPlant CEO

Mr. Yehiel Tal, Chief Executive Officer of CollPlant, has been elected to the Board of Directors of the International Society for Biofabrication (ISBF) for a three-year term starting January 1st 2022.

Mr. Tal was appointed to the Board of Directors of ISBF in recognition of his deep involvement, experience and understanding of the 3D bioprinting industry. The ISBF is a scientific and professional Society, which promotes advances in Biofabrication research, development, education, training, and medical and clinical applications. The ISBF’s core purpose is to foster scientific and technological innovation and excellence for the benefit of humanity.

“I am honored to be elected to the Board of Directors of the ISBF, and to work with others who are shaping and advancing the field of biofabrication which holds great promise in development of in vitro 3D models, tissue engineering and regenerative therapies” stated Mr. Tal.

“We are pleased to welcome Mr. Tal to ISBF’s Board of Directors,” stated Prof.  James J. Yoo, ISBF President, ”  Mr. Tal is a highly accomplished innovator in the field of 3D bioprinting and will bring a level of knowledge and passion that will greatly benefit our organization’s mission to foster scientific and technological advancement in the field of biofabrication that benefits humanity.”

The International Society for Biofabrication (ISBF) is a scientific and professional Society, which promotes advances in Biofabrication research, development, education, training, and medical and clinical applications. ISBF represents the international Biofabrication community and operate as a non-profit organization. ISBF’s core purpose is to foster scientific and technological innovation and excellence for the benefit of humanity. ISBF promote the interaction between the different disciplines of the field of Biofabrication, as well as between basic research and applied practice; and cooperate with other scientific organizations and communities.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version